Compound Detail
CHEMBL4591454
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4591454 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RCFAUUVPQUZGST-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
369.4
MW (Da)
2.72
ALogP
7
HBA
2
HBD
92.4
PSA (Ų)
0.73
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.74
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Ubiquitin carboxyl-terminal hydrolase 8 CHEMBL2157854 | IC50 | 4.74 | 4.74 | 18300.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 4.11 | 4.11 | 78300.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Ubiquitin carboxyl-terminal hydrolase 8 | IC50 | = | 18300.0 | nM | 4.74 | Inhibition of N-terminal His6-tagged USP8 (unknown origin) catalytic domain (734... | 35786929 |
| HepG2 | IC50 | = | 78300.0 | nM | 4.11 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 31238183 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31238183 | 10.1016/j.ejmech.2019.06.024 | CDK2/Cyclin A2 | 1 |
| 31238183 | 10.1016/j.ejmech.2019.06.024 | CDK9/cyclin T1 | 1 |
| 31238183 | 10.1016/j.ejmech.2019.06.024 | HepG2 | 1 |
| 35786929 | 10.1021/acs.jmedchem.2c00013 | Ubiquitin carboxyl-terminal hydrolase 8 | 1 |
Data from ChEMBL 36 via Core Engine